economic news – Neuroscience

There’s a new entry into the weight-loss drug boom. Here’s the stock’s outlook

November 9, 2023 by Wilma

AstraZeneca is the latest player to enter the weight-loss drug space, a market that some analysts say could reach $100 billion by 2030. On Thursday, the biopharmaceutical company announced it had entered into a licensing agreement with Eccogene for ECC5004 , an oral glucagon-like peptide 1 receptor agonist. This drug,… Continue Reading There’s a new entry into the weight-loss drug boom. Here’s the stock’s outlook

Wall Street is wondering what impact weight-loss drugs will have on consumer giants, but it may be too early to tell.

November 6, 2023 by Wilma

Delta Air Lines, Pepsi, Philip Morris International and Darden Restaurants are among companies facing questions about the impact of GLP-1 on their bottom lines. In the United States, only a fraction of obese people currently take a GLP-1. That figure could rise to 13% by the end of the decade,… Continue Reading Wall Street is wondering what impact weight-loss drugs will have on consumer giants, but it may be too early to tell.

FTC plans to hire child psychologist to guide internet rules

October 23, 2023 by Wilma

Monkeybusinessimages | Istock | Getty Images The Federal Trade Commission plans to hire at least one child psychologist who can guide its work on Internet regulation, Democratic Commissioner Alvaro Bedoya told The Record in an interview published Monday. FTC Chair Lina Khan supports the project, Bedoya told the outlet, adding… Continue Reading FTC plans to hire child psychologist to guide internet rules

Bank of America Sees Risks for Employers as Insurance Coverage of Weight Loss Drugs Increases

October 11, 2023 by Wilma

Eye-popping predictions for weight-loss drug sales hinge on insurance companies agreeing to provide coverage for expensive treatments, and momentum appears to be building on that front. But Allen Lutz, an analyst at Bank of America, wonders if employers know how risky the bet they’re making is. The hope is that… Continue Reading Bank of America Sees Risks for Employers as Insurance Coverage of Weight Loss Drugs Increases